Glenn Kerkhof, Chiltern CEO, stated, “Chiltern’s decision to increase our investment in endpoint reflects our aligned vision for the future of endpoint’s PULSE platform, enabling endpoint to provide a combination of premium client service and advanced technology solutions. Jon Dole and Tom O’Connell of endpoint have brought a new level of energy and innovation to Interactive Response Technology (IRT).”
PULSE is endpoint’s fully configurable system which allows users to design and deploy clinical trial IRT systems at a fraction of the time and cost of other providers, was launched in January 2010.PULSE simultaneously designs systems that can be accessed via the phone, web, or mobile device.
